AFTD Webinar: Diagnosing Primary Progressive Aphasia
With primary progressive aphasia (PPA), problems with language and communication typically deteriorate gradually over time. Initial symptoms are sometimes attributed to anxiety or stress until the ongoing symptoms become disruptive enough to prompt further assessment by a specialist. This webinar is intended for clinicians to support early detection and accurate diagnosis of PPA. Learners will…
Lees verderVertel uw wetgevers: Herautoriseer de financiering voor de Older Americans Act
You may think that because frontotemporal degeneration strikes many people in the middle of their life, that the Older Americans Act may not apply to you. But the OAA provides funding for services for adult family members and other adults who care for individuals with Alzheimer’s disease and related disorders in their home, regardless of…
Lees verderHoop bevorderen: AFTD organiseert 2024 FTD Research Roundtable Meeting
The FTD Research Roundtable is an annual program designed to accelerate FTD drug development by convening various scientific stakeholders to identify common challenges and advance solutions for FTD clinical trials. Biopharmaceutical companies currently conducting FTD pre-clinical and clinical trials are invited to join the FTD Research Roundtable, and in 2024, we were thrilled to have…
Lees verderBeschermd: A Conversation with Alector’s Vice President of Clinical Development
Er is geen samenvatting, omdat dit een beschermd bericht is.
Lees verderAC Immune en Life Molecular Imaging kondigen FDA Fast Track-aanduiding aan voor Tau PET-tracer
Swiss biopharmaceutical company AC Immune announced in late August that its partner, German biopharmaceutical company Life Molecular Imaging (LMI), received a Fast Track Designation from the US Food and Drug Administration (FDA) for a Tau PET tracer. PET, or positron emission tomography, is a form of medical imaging that uses a radioactive tracer to visualize…
Lees verderEmma Heming Willis deelt haar FTD-ervaring en haar pleitbezorgingswerk in het tijdschrift "Town & Country"
Emma Heming Willis spoke with journalist Katie Couric about her journey as an FTD care partner, as well as her advocacy for FTD legislation and research following the diagnosis of her husband, Bruce Willis, in an interview published in the November 2024 issue of “Town & Country.” For her ongoing advocacy work, Mrs. Willis will be…
Lees verder2024 Rijdende hoop voor FTD zeldzame Burbon en Scotch vakantieveiling
Alumni van de AFTD Board of Directors, Michael Stowell, organiseert de Driving Hope for FTD Rare Burbon and Scotch Holiday Auction van 2024, waarvan de opbrengst ten goede komt aan de missie van AFTD. Er zijn twee manieren om mee te doen aan dit evenement, voor de lokale bevolking en niet! Online veiling: vanaf nu tot en met 24 november kunt u bieden op zeldzame Buffalo Trace en…
Lees verderPersoonlijke ontmoeting en begroeting in Portland, Oregon
Meet actress and filmmaker Katie Prentiss to hear about her new full-length movie project, “Wake Up Maggie.” Hosts Allison Lindauer and David Spencer will provide drinks and appetizers at this open house, held on November 2, 2024, 4-6 PM. Donations for “Wake up Maggie” will be gladly received.
Lees verderBeschermd: Empower a Future Free of FTD with a Year-End Gift
Er is geen samenvatting, omdat dit een beschermd bericht is.
Lees verderVoortgang van hoop: AFTD woont bijeenkomst van onderzoekers van het Tau Consortium bij
Members of the AFTD staff, along with several funding partner organizations, gathered with the world’s top scientists studying tauopathies for the 2024 Tau Consortium Investigators Meeting (TCIM) this September in Denver. The Tau Consortium™ is a collaborative research program that is managed and funded by the Rainwater Charitable Foundation (RCF) that fosters collaboration and knowledge-sharing,…
Lees verder